Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | Journal Article | ||||||||||||
PMID | (39392364) | ||||||||||||
Authors | Arregui M, Calles A, Galera MDM, Gutiérrez A, López-Jiménez C, Agra C, Fernández A, Gutiérrez N, Toro M, Álvarez R | ||||||||||||
Title | Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor. | ||||||||||||
|
|||||||||||||
URL | |||||||||||||
Abstract Text | Glomus tumors (GT) are very rare mesenchymal neoplasms arising from glomus bodies, arteriovenous structures located in the dermis and involved in thermoregulation. Although most are benign, they may occasionally present malignant histological features associated with aggressive clinical behavior, metastatic spread, and poor response to conventional chemotherapy. The BRAF V600E mutation has been identified in a subset of malignant GT, highlighting a promising therapeutic target. Here, we report the impressive clinical and morpho-metabolic response of a metastatic BRAF V600E-mutated glomangiosarcoma after treatment with encorafenib and binimetinib. |